Degron Therapeutics logo

Degron Therapeutics jobs and careers

Shanghai, China

About Degron Therapeutics

Dago Bio aims to become the world's leading research and development company for innovative protein degradation drugs-molecular glue-based small molecule new drugs. The Dago team, composed of world-class managers and scientific leaders with international vision and rich industry experience, will focus on the discovery and verification of new, especially undruggable targets of traditional small molecule inhibitors, and the optimization of new compounds. Provide innovative solutions and paths in preclinical and clinical research. It can be used in all therapeutic areas, with the mission of benefiting human health and addressing unmet clinical medical needs.

Founded
2021
Employees
1 to 10
Total funding
$54M
Headquarters
Shanghai

Leadership

The top of Degron Therapeutics's org chart, with how many people report into each leader.

LZPhoto of Lily Zou

Lily Zou

CEO, Co-Founder

3 reports

YCPhoto of Yong Cang

Yong Cang

CSO, Co-Founder

XQPhoto of Xiaobing Qian

Xiaobing Qian

Chief Development Officer

MAPhoto of Mark Ashwell

Mark Ashwell

Global Head of Chemistry